Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 587

1.

Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.

Pizzi M, Piazza F, Agostinelli C, Fuligni F, Benvenuti P, Mandato E, Casellato A, Rugge M, Semenzato G, Pileri SA.

Oncotarget. 2015 Jan 31. [Epub ahead of print]

2.

BRAFV 600E mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients.

Sellar RS, Fend F, Akarca AU, Agostinelli C, Shende V, Quintanilla-Martínez L, Stein H, Pileri SA, Linch D, Marafioti T.

Br J Haematol. 2015 Mar 10. doi: 10.1111/bjh.13291. [Epub ahead of print] No abstract available.

PMID:
25758903
3.

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Alinari L, Mahasenan KV, Yan F, Karkhanis V, Chung JH, Smith EM, Quinion C, Smith PL, Kim L, Patton JT, Lapalombella R, Yu B, Wu Y, Roy S, De Leo A, Pileri S, Agostinelli C, Ayers L, Bradner JE, Chen-Kiang S, Elemento O, Motiwala T, Majumder S, Byrd JC, Jacob S, Sif S, Li C, Baiocchi RA.

Blood. 2015 Mar 5. pii: blood-2014-12-619783. [Epub ahead of print]

PMID:
25742700
4.

Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum?

Pileri A, Agostinelli C, Grandi V, Raone B, Delfino C, Patrizi A, Pileri SA, Pimpinelli N.

G Ital Dermatol Venereol. 2014 Dec;149(6):639-42.

PMID:
25664821
5.

CD30 detection in haematological malignancies: diagnosis and therapeutics.

Pileri S, Kwong YL, Tan LH, Ohshima K.

Leuk Res. 2015 Mar;39(3):388. doi: 10.1016/j.leukres.2014.12.004. Epub 2014 Dec 11. No abstract available.

PMID:
25636355
6.

CD103 marks a subset of human CD34(+)-derived langerin(+) dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1.

Očadlíková D, Trabanelli S, Salvestrini V, Ciciarello M, Evangelisti C, Lecciso M, Sabattini E, Righi S, Piccioli M, Pileri SA, Lemoli RM, Curti A.

Exp Hematol. 2015 Apr;43(4):268-276.e5. doi: 10.1016/j.exphem.2014.12.007. Epub 2015 Jan 10.

PMID:
25584868
7.

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.

Navari M, Fuligni F, Laginestra MA, Etebari M, Ambrosio MR, Sapienza MR, Rossi M, De Falco G, Gibellini D, Tripodo C, Pileri SA, Leoncini L, Piccaluga PP.

Front Microbiol. 2014 Dec 23;5:728. doi: 10.3389/fmicb.2014.00728. eCollection 2014.

8.

Fatal necrotizing angiotropic Epstein-Barr virus-negative large B-cell lymphoma: a case report with unusual clinicopathological features in-between lymphomatoid granulomatosis and T-cell/histiocyte-rich large B-cell lymphoma.

Olivieri A, Sabattini E, Goteri G, Trappolini S, Saraceni F, Samorì A, Gini G, Leoni P, Olivieri J, Pileri SA.

Medicine (Baltimore). 2014 Dec;93(29):e353. doi: 10.1097/MD.0000000000000353.

PMID:
25546693
9.

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma.

Derenzini E, Agostinelli C, Imbrogno E, Iacobucci I, Casadei B, Brighenti E, Righi S, Fuligni F, Ghelli Luserna Di Rorà A, Ferrari A, Martinelli G, Pileri S, Zinzani PL.

Oncotarget. 2014 Nov 28. [Epub ahead of print]

10.

A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.

Abate F, Todaro M, van der Krogt JA, Boi M, Landra I, Machiorlatti R, Tabbò F, Messana K, Abele C, Barreca A, Novero D, Gaudiano M, Aliberti S, Di Giacomo F, Tousseyn T, Lasorsa E, Crescenzo R, Bessone L, Ficarra E, Acquaviva A, Rinaldi A, Ponzoni M, Longo DL, Aime S, Cheng M, Ruggeri B, Piccaluga PP, Pileri S, Tiacci E, Falini B, Pera-Gresely B, Cerchietti L, Iqbal J, Chan WC, Shultz LD, Kwee I, Piva R, Wlodarska I, Rabadan R, Bertoni F, Inghirami G; The European T-cell Lymphoma Study Group.

Leukemia. 2014 Dec 23. doi: 10.1038/leu.2014.347. [Epub ahead of print]

PMID:
25533804
11.

Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.

Inghirami G, Chan WC, Pileri S; AIRC 5xMille consortium ‘Genetics-driven targeted management of lymphoid malignancies’.

Immunol Rev. 2015 Jan;263(1):124-59. doi: 10.1111/imr.12248.

PMID:
25510275
12.

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, Sapienza MR, Motta G, Gazzola A, Mannu C, Sabattini E, Bacci F, Tabanelli V, Sacchetti CA, Barrese TZ, Etebari M, Melle F, Clò A, Gibellini D, Tripodo C, Inghirami G, Croce CM, Pileri SA.

Blood Cancer J. 2014 Nov 7;4:259. doi: 10.1038/bcj.2014.78.

13.

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.

Piva R, Deaglio S, Famà R, Buonincontri R, Scarfò I, Bruscaggin A, Mereu E, Serra S, Spina V, Brusa D, Garaffo G, Monti S, Dal Bo M, Marasca R, Arcaini L, Neri A, Gattei V, Paulli M, Tiacci E, Bertoni F, Pileri SA, Foà R, Inghirami G, Gaidano G, Rossi D.

Leukemia. 2015 Feb;29(2):503-7. doi: 10.1038/leu.2014.294. Epub 2014 Oct 6. No abstract available.

PMID:
25283840
14.

The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.

Zinzani PL, Broccoli A, Casadei B, Stefoni V, Pellegrini C, Gandolfi L, Maglie R, Argnani L, Pileri S, Fanti S.

Hematol Oncol. 2014 Sep 25. doi: 10.1002/hon.2172. [Epub ahead of print]

PMID:
25256959
15.

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma.

Pellegrini C, Maglie R, Argnani L, Pileri S, Zinzani PL.

Hematol Oncol. 2014 Sep 22. doi: 10.1002/hon.2163. [Epub ahead of print] No abstract available.

PMID:
25243375
16.

Hematopathology: LC14-1 DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): STILL A PANDORA'S BOX?

Pileri SA.

Pathology. 2014 Oct;46 Suppl 2:S21. doi: 10.1097/01.PAT.0000454120.28470.02.

PMID:
25188094
17.

A unique case of an indolent myometrial T-cell lymphoproliferative disorder with phenotypic features resembling uterine CD8+ resident memory T cells.

Tabanelli V, Valli R, Righi S, Nucera G, Zecchini Barrese T, Pileri S, Sabattini E.

Pathobiology. 2014;81(4):176-82. doi: 10.1159/000363346. Epub 2014 Aug 14.

PMID:
25138577
18.

Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.

Agostinelli C, Rizvi H, Paterson J, Shende V, Akarca AU, Agostini E, Fuligni F, Righi S, Spagnolo S, Piccaluga PP, Clark EA, Pileri SA, Marafioti T.

Am J Surg Pathol. 2014 Oct;38(10):1349-59. doi: 10.1097/PAS.0000000000000309.

PMID:
25118816
19.

Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network.

Mannu C, Gazzola A, Ciabatti E, Fuligni F, Cavalli M, Della Starza I, Genuardi E, Mantoan B, Monitillo L, Del Giudice I, Ladetto M, Gaidano G, Sabattini E, Pileri SA, Galimberti S, Piccaluga PP; Fondazione Italiana Linfomi Minimal Residual Disease Network.

Leuk Lymphoma. 2015 Mar 11:1-11. [Epub ahead of print]

PMID:
25115509
20.

Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies.

Swerdlow SH, Jaffe ES, Brousset P, Chan JK, de Leval L, Gaulard P, Harris NL, Pileri S, Weiss LM; International Lymphoma Study Group.

Am J Surg Pathol. 2014 Oct;38(10):e60-71. doi: 10.1097/PAS.0000000000000295. Review.

PMID:
25025449
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk